Untargeted UHPLC-MS/MS analysis of intestines of high-value Apostichopus Japonicus: A proof of concept Authors: Piaopiao Jiang, Xu Zhou, Yun Hu, Jin Zhang, Boyan Li, Zhongda Zeng Published: 2026 ABSTRACT AbstractThis study articulated the intestinal metabolome of Apostichopus japonicus, one of the most geographically indicated high-value aquatic products in China. Through untargeted UHPLC-MS/MS metabolomic analysis, 645 metabolites were annotated from a total of 6333 detected spectral features in the body wall and intestinal tissues of A. japonicus. These substances constituted the primary metabolic profile of the body wall and intestines. Statistical analysis identified 208 differential metabolites and seven significantly enriched metabolic pathways. Among them, 172 metabolites were upregulated in the intestine, accounting for a proportion of 82.69%. The use of integrated bioaccessibility response method allowed for a quantitative and concise gauge of metabolic alterations including upregulation and downregulation of metabolites between intestinal and body wall samples. The work helped understand the nutritional aspects of A. japonicus intestine and support its potential utility in food processing and health-related applications.Keywords: Apostichopus japonicus, Intestine, Geographical indication product, Integrated bioaccessibility response, UHPLC-MS/MS Introduction Apostichopus japonicus (A. japonicus) is an invertebrate aquatic species belonging to the Echinodermata phylum in the class of holothuroidea (Yang, Hamel, & Mercier, 2015). This species plays important roles in regulating shallow marine ecosystems, by altering the characteristics of coral reef habitat sediments, increasing dissolved oxygen concentration in sediments, and promoting the diffusion of organic matter into water (Ennas et al., 2023). A. japonicus notable for its significant nutritive and economic worth stands as one of the foremost mariculture species in northern China and edible materials. Its nature of high protein, low fat and palatable taste makes A. japonicus a renowned and prestigious delicacy in Chinese diets (Li et al., 2021). This was primitively documented in an authoritative ancient Chinese medical classic named the Supplement to the Compendium of Materia Medica (1765 CE, Qing Dynasty). A. japonicus consists of abundant bioactive polysaccharides (Gai et al., 2025; Saeid, Dave, & Shahidi, 2025), saponins (Qi et al., 2026; Zhao et al., 2025), a rich profile of amino acids essential for humans (Lu et al., 2024). Studies have shown the potential of these bioactive substances in offering anti-diabetic (Meng et al., 2018), anti-tumor (Dai et al., 2020; Zhang et al., 2024), immunomodulatory (Yang, Lin, Huang, Ye, & Xiao, 2020), neuroprotective (Zhao, Lu, Xu, Sun, & Lin, 2022), and antioxidant benefits (Lu, Sun, Dong, Gao, & Lin, 2022). For instance, collagen and its hydrolyzed small molecular peptides from A. japonicus are easily digested and absorbed. They may exert auxiliary regulatory effects on blood glucose control by improving insulin signaling pathways and reducing insulin resistance (Shou et al., 2023). Chondroitin sulfate-like polysaccharides and fucosylated glycosaminoglycans possess potential activities in regulating blood glucose, improving lipid metabolism, and protecting pancreatic islet β-cells (Gong et al., 2022). A triterpenoid saponin of holothurin exhibits potential anti-inflammatory and immune-regulating effects (Li et al., 2022; Puspitasari et al., 2023). Therefore, A. japonicus has attracted extensive attention and served particular functions in traditional medicines or health-promoting products (Lu et al., 2022). A. japonicus is mainly distributed in the Northwest Pacific Ocean, the Yellow Sea, the Sea of Japan, and the Sea of Okhotsk (Purcell et al., 2023). In China, it is found on the coasts of Liaoning, Hebei and Shandong provinces. Today, wild stocks are essentially gone and A. japonicus is almost exclusively farmed (Mercier, Penney, Ma, Lovatelli, & Hamel, 2023). According to the 2025 Blue Paper on High-Quality Development of Dalian Sea Cucumber Industry released in January 2026, as of 2025 the cumulative value of the entire A. japonicus industry in Dalian escalated to approximately 4.2 billion dollars. It was Dalian of Liaoning province that dominated an annual output of more than 85,000 t, accounting for 29% of the national total. A. japonicus became one of the most geographically indicated high-value aquatic products, and was approved as Dalian Sea Cucumber for local stock protection since 2005 (Note, n.d.). The China Agricultural Brand Directory included this geographical indication product in 2019. A. japonicus has a leathery tough skin and an elongated body containing a single branched gonad. Its body wall consists of an epidermis and a dermis with smaller calcareous ossicles (Fig. S1 in the Supporting Information). Inside the body wall is the coelom which is divided by three longitudinal mesenteries which surround and support the internal organs. The modalities of human consumption of A. japonicus include bêche-de-mer, intestines or dried gonads either as culinary foods or in various forms for nutritional and medicinal purposes. However, within the commercial trade of A. japonicus, it is standard industry practice to eviscerate the product post-harvest, only retaining the body wall for sale (Muhsin et al., 2023). To date, nutritive investigations of A. japonicus have been predominantly carried out on the orthodox edible body wall, while far less attention has been directed toward its visceral tissues and non-conventional edible intestines (Xing, Sun, Liu, Zhang, & Yang, 2021). Furthermore, although substantial research focus has been placed on major macromolecules within the body wall, such as proteins and carbohydrates (Ge et al., 2026; Qi et al., 2026), metabolomic studies targeting small molecular compounds in the intestines remain relatively scarce (Lu et al., 2024; Saeid et al., 2025). The present study aimed to articulate the metabolome of the intestine and body wall of A. japonicus produced in geographically indicated locations near Dalian Bohai Bay, using an untargeted UHPLC-MS/MS approach. The outcomes of differential metabolites and pathways between the intestine and body wall helped better understand the nutritive value of intestines of A. japonicus. This baseline metabolic dataset had the potential to support high-value food processing of A. japonicus intestine and underpin the development of intestinal-derived functional products. Materials and methods Materials and chemicals A total of thirty raw materials of fresh A. japonicus under investigation were purchased from local aquaculture farmers in Dalian, which were collected from the Jinshitan coastal waters in March 2023. Jinshitan is a core traditional producing area and national-level aquatic germplasm resource reserve for A. japonicus, of which the environmental conditions including water temperature, salinity, sediment, and bait organisms, are highly conducive to the growth of A. japonicus, making it a representative origin for high-quality A. japonicus. All specimens were three years in age, with an average weight of approximately 100 g for each. Upon collection, the materials were immediately transported to laboratory where samples were promptly washed, dissected, and thus the body wall and intestines were both acquired. These tissues were then placed into sealed bags and sample vials respectively, labeled with individual identity numbers, and stored in a freezer at −80 °C for subsequent analysis. The sample size was determined a priori based on a power analysis by setting key parameters as follows: a large effect size (Cohen's d) = 0.75, a significance level α = 0.05, and an adequate statistical power (1–β) = 0.80. This allowed for 30 biological replicates allocated to each experimental group of body wall (viz. group B) and intestine (group C). Methanol (HPLC ≥99.9%) was supplied by Merck (Darmstadt, Hesse, Germany). Acetonitrile (HPLC ≥99.9%) and formic acid (LC-MS grade) were received from Fisher Scientific (Waltham, MA, USA). Distilled water was produced by the Watsons Group (Hong Kong, China). Sample preparation Approximately 60 mg of each sample was placed into an Eppendorf tube of 1.5 mL, with an addition of 200 μL of distilled water. The samples were then homogenized using a YM-48 tissue homogenizer (YM, China) for 2 min and vortexed for 2 min. Subsequently, 800 μL of a mixture solution of methanol and acetonitrile (v/v = 1:1) was added to each homogenate matrix, followed by a 2 min vortex, and then subjected to an ultrasonic incubation with ice-cold water for 30 min. Each sample was allowed to stand at −20 °C for 1 h, and subsequently centrifuged at 14,000g and 4 °C for 20 min, yielding a supernatant. 800 μL of supernatant was taken out and concentrated on a concentrator to dryness, and then stored at −20 °C until further analysis. Prior to the UHPLC-MS/MS assay, each dried sample was dissolved in 100 μL of methanol-water solution (v/v = 1:4) and centrifuged. Supernatant was then collected as test sample. Quality control (QC) sample was prepared by pooling 10 μL of each supernatant aliquot from all the individual test samples and mixing together, which served as a routine standard sample to monitor the UHPLC-MS/MS instrumentation in real time and to calibrate the data responses. UHPLC-MS/MS assay The UHPLC-MS/MS analysis was conducted on an Ultimate 3000 UHPLC system (UltiMate™ 3000, Thermo Fisher Scientific) coupled with a Q-Exactive high-resolution mass spectrometer (Q Exactive™, Thermo Fisher Scientific). Chromatographic separation was achieved respectively using a BEH C8 column (100 mm × 2.1 mm, 1.7 μm, Waters Corporation) for the positive ion mode and an HSS T3 column (100 mm × 2.1 mm, 1.8 μm, Waters Corporation) for the negative ion mode. Column temperature was maintained at 50 °C, with a flow rate of 0.35 mL/min and an injection volume of 5 μL for each sample. The mobile phase consisted of A (water containing 0.1% formic acid) and B (acetonitrile with 0.1% formic acid). The gradient eluting procedure for positive ion mode was as follows: 0–1.0 min, 5% B; 1.0–11.0 min, 5–100% B; 11.0–13.0 min, 100% B; 13.0–15.0 min, 5% B. While for negative ion mode the eluting procedure was some different as such: 0–1.0 min, 5% B; 1.0–3.0 min, 5–30% B; 3.0–6.0 min, 30–55% B; 6.0–11.0 min, 55–65% B; 11.0–13.0 min, 65–100% B; 13.0–15.0 min, 5% B. Throughout the UHPLC-MS/MS analysis, QC sample was tested every ten samples to monitor instrumental stability and experimental reproducibility. Mass spectrometer was operated with a heated electrospray ionization source (HESI) in both positive and negative polarity modes with a spray voltage of +3.8 kV (ESI+) and − 3.0 kV (ESI−), capillary temperature of 320 °C. Auxiliary gas heater temperature was 350 °C and the flow rates of sheath gas and auxiliary gas were 35 and 8 in arbitrary unit, respectively. S-lens RF level was 50. The mass-to-charge ratio (m/z) range was 70–1050 with a mass resolution of 70,000 and MS/MS resolution of 17,500. The data-dependent acquisition (DDA)-based mass fragment (MS2) scans were automatically determined. Metabolite annotation The UHPLC-MS/MS data were processed with the platform of MExplorer Ultimate (V1.3.0.234, Dalian Dashuo Information Technology Co., Ltd.) in terms of a series of data handling tasks of peak extraction, baseline correction, signal deconvolution, and peak alignment, among others. A peak table of metabolites was ultimately generated, not only including the qualitative list of retention time (tR), precursor ion (MS1), and mass fragment (MS2) of each annotated metabolite but also the quantitative information of peak areas. Metabolites were tentatively annotated using tR, together with MS1 and MS2 spectral features. Annotation was achieved via database searching, spectral similarity scoring, and putative compound matching against entries retrieved from one proprietary database (Dalian Dashuo Information Technology Co., Ltd.) and four public databases including Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa, Furumichi, Tanabe, Sato, & Morishima, 2017), Human Metabolome Database (HMDB) (Wishart, Guo, Oler, et al., 2022), Chemical Entities of Biological Interest (ChEBI) (Hastings, Owen, Dekker, et al., 2016), and PubChem (Kim, Chen, Cheng, et al., 2019; Sumner, Amberg, Barrett, et al., 2007). Data processing and statistical analysis Initially, metabolites with ≥50% missing values were removed from the peak table. Using the interquartile range method, outliers that exceeded 1.5 times the interquartile range were excluded from subsequent analysis of metabolic data. Following these steps, the remaining missing values were imputed by means of the minimal value approximation. Metabolites with a relative standard deviation larger than 30% in QC samples were filtered out. Data normalization was carried out through sum normalization, log10 transformation and autoscaling. Principal component analysis (PCA) (Jolliffe & Cadima, 2016) was implemented to observe clustering and dispersion among samples. A threshold of p < 0.05 was set to determine significant differences in metabolites between groups either with one-sample t-test or Wilcoxon test. p < 0.01 indicated a highly significant difference. Fold change (FC) between groups B and C was presented to observe the metabolite variations. According to the criterion that variable importance in projection (VIP) value was larger than 1.0, differential metabolites were identified. The Benjamini-Hochberg method was applied to correct p-value in student's t-test and control the overall false discovery rate, with p.adjust in R statistical package (version 4.2.3). Metabolomic analysis was performed with MetaboAnalyst 5.0 (Pang, Zhou, Ewald, et al., 2022), such as PCA and orthogonal partial least squares-discriminant analysis (OPLS-DA) (Kuligowski, Moreno-Torres, & Quintás, 2024). Finally, the integrated bioaccessibility response (IBR) approach proposed in a recent study (Li, He, Chen, et al., 2025) was adopted to quantitatively gauge the overall differences of differential metabolites of interest between intestinal and body wall samples of A. japonicus. This method integrated peak area responses of multiple metabolites into a single multivariate metric. Full calculation procedure for the IBR index was provided in the Supporting Information. Metabolomic pathway analysis Metabolomic pathway analysis was made through running MBROLE 2.0 (http://csbg.cnb.csic.es/mbrole2) (López-Ibáñez, Pazos, & Chagoyen, 2016) with the input of significant metabolites. Library searching of species was confined to Homo sapiens. Enrichment analysis encompassed KEGG, SMPDB (HMDB) and BioCyc pathways, as well as HMDB biofunctions, ChEBI and KEGG roles. Pathway overrepresentation analysis was assessed using a cumulative hypergeometric test. Metabolomic pathways with p < 0.05 were considered to be significantly different between groups B and C. Results and discussion Metabolomic profiles of intestine and body wall Fig. 1a showed the total ionic chromatograms (TICs) of UHPLC-MS/MS data acquired from one QC sample in both positive (ESI+) and negative (ESI−) ion modes, within the analysis time of 15.0 min. It can be observed that the peaks with high abundance in the samples corresponding to the ESI+ mode mostly appeared within 2.0–10.0 min, while those with high abundance under the ESI− conditions eluted in the range of 6.0–8.0 min. There were totally 6333 metabolite features detected from the intestine and body wall samples, including 1462 features in positive mode and 4871 features in negative mode. Metabolite annotations were tentatively performed through database searching, spectral similarity scoring, and putative compound matching against database entries. After data processing, a peak table comprised of 645 annotated metabolites was generated, with detailed information summarized in the Supporting Information Table S1. Notably, 25 of the 645 metabolites were annotated by matching experimentally measured tR and MS1/MS2 masses with entries of reference compounds in the proprietary database, accounting for 3.88%. The remaining 620 metabolites were annotated by comparing experimental MS1 and MS2 spectra with theoretical exact masses and putative ion adducts from public databases, corresponding to 96.12% of all annotated metabolites. Collectively, this set of 645 metabolites constituted the primary metabolic profile of body wall (group B) and intestine (group C) samples of A. japonicus. (a) Total ionic chromatograms (TICs) of UHPLC-MS/MS data of one QC sample. (b) Heatmap of 645 metabolites in the body wall (Group B), intestine (Group C), and QC samples in clustering analysis. (c) Biochemical categories of 645 metabolites. (d) PCA scores plot of A. japonicus intestine and body wall samples. Ellipse signified a 95% confident level. Using the Euclidean distance for similarity metric and Ward's linkage method upon the peak area data after being preprocessed with mean-centering and standardization, hierarchical clustering of these metabolites were carried out. A heatmap was therefrom constructed (Fig. 1b), wherein colour gradient shifted from blue to red, representing the relative metabolite abundance, from low intensity to high intensity. As visualized in the heatmap, the samples from groups B and C were clearly separated into two distinct clusters, indicating statistically pronounced tissue-specific metabolic differences. A large subset of metabolites exhibited high red/orange expression in group B but low blue/white expression in group C, while another subset showed the opposite pattern, suggesting tissue-enriched metabolites. In contrast, six QC samples showed more consistent colour patterns without apparent orange/blue variations, confirming the reliability and reproducibility of the metabolomic detection. Close inspection of the metabolite profiles revealed that organic acids and derivatives constituted the largest metabolite class, accounting for a proportion of 22.95% (148 out of 645 annotated metabolites). This was followed by lipids and lipid-like molecules (18.91%) and organoheterocyclic compounds (17.67%). The classification of these metabolites was summarized in Fig. 1c. The PCA result from the processed peak area data showed a clear separation along the first principal component (PC1 explained 38.04% of the variance of the data) between the sample scores of groups B and C (Fig. 1d), highlighting significant differences in their metabolite profiles. Within each group, the sample scores formed tight clusters at a 95% confident level, indicating high homogeneity in metabolite characteristics among biological replicates. Particularly, QC samples gathered closely together, implying the stability of the experimental detection and the reliability of the data processing pipeline. Furthermore, the QC samples exhibited a closer proximity to the intestinal samples of group C than to those of group B. This suggested that the metabolite profiles were predominantly influenced by the sample aliquots from group C. The experiment adopted a simple method combining tissue grinding with methanol-acetonitrile mixture extraction. The ease of extracting constituent substances from the intestines of A. japonicas and their contents differed to the body wall. The body wall is a complex structure, typically comprising three layers from the outside in: (1) the epidermal layer, rich in collagen fibers; (2) the dermis layer, largely composed of elastic fibers; and (3) the medullary cavity layer, which serves as the primary nutrient storage region, containing proteins, polysaccharides, saponins, and peptides, among other components. The extracellular matrix of connective tissue mainly in dermis layer is a gelatinous substance composed of biological macromolecules such as proteoglycans and glycoproteins. The main structural components of the intestines are mucosa, submucosa, muscularis and serosa layers. Therefore, compared to the body wall, the intestinal tissue was more easily ground into fragments, and more small molecular metabolites could be extracted by use of the methanol-acetonitrile mixture. Differential metabolites Each of the 645 annotated metabolites was subjected to the univariate statistics using a one-sample t-test (or Wilcoxon test) and fold change (FC) analysis for a preliminary screen of differential metabolites between groups B and C. The screening criteria were set as p < 0.05 with either FC > 1.50 or FC < 0.67. After adjusting p-values for false discovery rate (FDR), 334 differential metabolites were discerned. Fig. 2a visualized the expression trend of these differential metabolites: 54 metabolites in the body wall samples were upregulated (marked with •Up), in comparison with the intestinal extract samples, while 280 metabolites showed a downregulating trend (marked with •Down). By contrast, the remaining 311 metabolites showed no significant differences between two groups, as represented by grey solid circles (•Non-Sig) in the volcano plot. (a) Volcano plot of 645 differential metabolites in body wall and intestine samples. (b) Scores plot and (c) VIP values of 645 differential metabolites resulted from OPLS-DA. “Non-Sig” and “Sig” denoted non-significant and significant respectively. (d) Biochemical categories and (e) clustering heatmap of 208 key differential metabolites. To further identify significant differential metabolites, OPLS-DA was additionally applied to the processed peak area data of the 645 metabolites. Model performance was evaluated using cross-validation with 1000 permutation tests. The score plot illustrated that these metabolites were able to distinguish the body wall and intestine samples, with the first predictive component explaining 37.30% of the variance in the processed data that discriminated the two groups (Fig. 2b). 320 significant differential metabolites were identified from the total 645, based on a predefined threshold of VIP > 1.0 in the OPLS-DA model (Fig. 2c). The model parameter of R2Y = 0.991 indicated good explanation of class variation, while a Q2 value of 0.975 (close to 1.0) and p < 0.001 (Fig. S2 in the Supporting Information) confirmed the predictive ability and suitability of the OPLS-DA model. Taking into consideration the results of the OPLS-DA VIP values, univariate statistics and fold change analysis mentioned above, a total of 208 key differential metabolites were finally identified on the criteria of p < 0.05, FC > 1.50 or FC < 0.67, and VIP > 1.0. The 208 metabolites were across 14 distinct categories (Fig. 2d and the Supporting Information Table S1). Among them, 56 lipids and lipid-like molecules constituted 26.92% of the total, 40 organic acids and derivatives accounted for 19.23%, 33 organoheterocyclic compounds for 15.86%, and 23 benzenoids for 11.06%, representing the four most abundant categories. Fig. 2e displayed the clustering heatmap of the 208 differential metabolites, resulted from implementing the Euclidean distance similarity and Ward's linkage methods. In the heatmap, the colour gradient from red to blue corresponded to a descending trend in the relative peak area intensity of differential metabolites. Specific attention should be given to the majority of differential metabolites, mainly including lipids and lipid-like molecules, organic acids and their derivatives, as well as nucleosides, nucleotides and analogues. They were at significantly higher levels in the intestinal extracts than in the body wall (coloured with red/orange on the group C panel in Fig. 2e), while only a small proportion of metabolites showed higher abundance in the body wall (red/orange colour on the group B panel in Fig. 2e). These findings implied that: (1) the intestine was rich in diverse nutrients, with partial compositions similar to those in the body wall composed of the epidermis, dermis, muscle layers and connective tissue; (2) metabolites in the intestine were more easily extracted during experimental procedures compared with those in the body wall; and (3) the intestine possessed considerable nutritive value and potential for commercial exploitation and utilization of A. japonicus intestines. Notably, the intestine accumulated abundant amino acids, especially those human essential amino acids with favourable digestibility and absorbability, which might render it an ideal nutritional supplement for populations with impaired digestive function. Moreover, the intestines contained higher levels of bioactive saponins, the signature functional ingredients of A. japonicus. Despite these valuable nutritional and functional properties, most small- and medium-sized enterprises processing A. japonicus have historically discarded intestines directly as fishery waste. This practice arose from three industrial bottlenecks: (i) high labour costs associated with complete sediment removal; (ii) rapid deterioration of intestinal raw materials even during short-term storage; and (iii) inadequate supporting cold-chain systems and dedicated processing infrastructure. Discarded intestinal tissues were previously discharged alongside processing wastewater and solid residues. Such unregulated disposal posed potential environmental risks. Accordingly, these dumping practices are subject to increasingly stringent regulation in fishery industrial parks across many coastal regions. Currently, there are two dominant industrial utilization routes for A. japonicus intestines. The mainstream practice consists of simple collection and temporary refrigerated storage of intestines during processing, followed by bulk selling to feed manufacturers as raw materials for aquafeed and pet feed, corresponding to a low-value primary processing mode. The second intensive processing strategy employs enzymatic hydrolysis to convert intestinal materials into protein hydrolysate, which has been officially listed in the Feed Raw Material Catalogue issued by the Ministry of Agriculture and Rural Affairs of China (Ministry of Agriculture and Rural Affairs of the People's Republic of China, 2026). Even so, high-value extraction and deep processing are only carried out by a small number of large-scale enterprises furnished with sophisticated production lines. A. japonicus intestines contain abundant essential amino acids and high levels of bioactive saponins. These constituents may serve as specific targets for separation and purification to develop intestinal-derived food and functional products. Accordingly, such exploitation could facilitate the transition of this resource from low-grade feed raw materials to high-value food and health commodities. Metabolomic pathways To explore metabolic differences and the biological functions of key differential metabolites between intestine and body-wall tissues, KEGG pathway enrichment analysis was conducted on the 208 differential metabolites. In total, 40 metabolic pathways were identified, among which the top 10 pathways with the smallest p-values are presented in Fig. 3. In this bubble plot, the size of each circle corresponded to the number of differential metabolites enriched in the respective pathway, and larger circles meant a greater count of differential metabolites. Circle colour denoted the pathway's significance level, with darker colours representing higher statistical significance. Bubble plot of enriched metabolic pathways with key differential metabolites. Seven significant enriched pathways with p < 0.05 included arachidonic acid metabolism, pyrimidine metabolism, purine metabolism, glycerophospholipid metabolism, tryptophan metabolism, arginine and proline metabolism, and cysteine and methionine metabolism (Table 1). Each metabolic pathway was associated with at least three metabolites as illustrated in Fig. 4, wherein red and blue markers denoted upregulated and downregulated metabolites respectively. For instance, the arachidonic acid metabolism pathway linked eight paramount metabolites, all belonging to fatty acids and lipid-like molecules, viz. prostaglandin F2α (C00639), hepoxilin B3 (C14810), leukotriene B4 (C02165), 5(S)-hydroxyeicosatetraenoic acid (5-HETE, C04805), prostaglandin A2 (C05953), 15-hydroperoxyeicosatetraenoic acid (15(S)-HPETE, C05966), 8-isoprostaglandin F2α (C13809), and 5-ketoeicosatetraenoic acid (5-oxo-ETE, C14732). The pathways of arginine and proline metabolism, as well as tryptophan metabolism, contained metabolites including L-homocarnosine (C00884), (3R,5S)-1-pyrroline-3-hydroxy-5-carboxylic acid (C04281), 4-(glutamylamino) butanoate (C15767), 5-hydroxy-L-tryptophan (C00643), L-formylkynurenine (C02700), 5-methoxytryptamine (C05659), and N-ω-methyltryptamine (C06213). Glycerophospholipid metabolism was mainly modulated by alterations in metabolite levels such as glycerophosphocholine (C00670), N-methylethanolaminium phosphate (C01210), and glycerophosphoethanolamine (C01233). Purine metabolism involved four metabolites: deoxyinosine (C05512), guanine (C00242), guanosine (C00387), and guanosine monophosphate (C00144). Particularly, there was a direct conversion relationship among four metabolites within pyrimidine metabolism, namely uridine monophosphate (C00105), uridine (C00299), cytidine (C00475), and cytidine 3′-monophosphate (3’-CMP, C05822). All of these indicated that fatty acids, amino acids, and glycerophospholipids exerted crucial roles in energy metabolism and vital functional regulation during metabolic processes of A. japonicus. Close scrutiny disclosed that among the 208 differential metabolites, 172 ones were upregulated in intestine tissues, accounting for 82.69% of the total, whereas the remaining 36 metabolites showed downregulated trends in their expressions. Table 1Significant enriched metabolism pathways and corresponding integrated bioaccessibility responses (IBRs) resulted from the differential metabolites of intestine (group C) and body wall (group B) extracts, in terms of median IBR value and ratio of C-to-B (C/B).Pathwayp valueIBR (C)IBR (B)Ratio (C/B)Arachidonic acid metabolism1.04 × 10−57.335.97 × 10−2122.84Pyrimidine metabolism1.59 × 10−32.676.27 × 10−242.57Purine metabolism1.61 × 10−24.731.75 × 10−2270.90Glycerophospholipid metabolism2.96 × 10−22.360.36 × 10−2649.74Tryptophan metabolism3.06 × 10−22.460.74 × 10−2333.89Arginine and proline metabolism3.18 × 10−22.353.90 × 10−260.23Cysteine and methionine metabolism4.88 × 10−22.031.67 × 10−2121.24 Significant enriched metabolism pathways and corresponding integrated bioaccessibility responses (IBRs) resulted from the differential metabolites of intestine (group C) and body wall (group B) extracts, in terms of median IBR value and ratio of C-to-B (C/B). Paramount metabolic pathways accounting for differences between the body wall (left) and intestine (right) extract samples of A. japonicus. Red and blue marks denoted upregulated and downregulated respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Pathway enrichment analysis was implemented via MBROLE 2.0 using the Homo sapiens reference database derived from KEGG. Owing to the limited metabolic annotation resources for A. japonicus in public databases, human-derived metabolic pathways were employed as a surrogate reference to interpret metabolite-level enrichment patterns. This analysis provided only exploratory valuable insights into the divergent metabolic profiles between the intestinal and body wall extracts and improved our understanding of the nutritional aspects of intestines, rather than capturing the species-specific physiological pathways of A. japonicus. The enrichment of bioactive metabolites indicated a higher biosynthetic/accumulation level in the intestine, and this tissue was likely to be a promising resource with substantial potential for high-value utilization. Integrated bioaccessibility response quantification According to the principle (Integrated bioaccessibility response in the Supporting Information), IBR values were computed by means of the peak area data of the pivotal differential metabolites in each enriched metabolic pathway. It allowed for a quantitative and concise comparison of their upregulation or downregulation behaviours in the intestine and body wall. For illustrative purposes, the eight fatty acids and lipid-like substances (i.e., C05953, C00639, C14810, C13809, C02165, C04805, C05966 and C14732) involved in the arachidonic acid metabolism pathway were taken as an example. The peak area responses of these metabolites in each sample were represented by eight radial coordinates in a star plot (Fig. 5). These coordinates were arranged counter-clockwise in sequence, beginning with metabolite C05953, followed by C00639, and concluding with C14732. The star plot was constructed by calculating the average peak area responses of the common metabolites across individual samples of body wall and intestine extracts, respectively. The star plot revealed distinct total areas of IBR values (say the coloured patches in Fig. 5) between intestinal and body wall samples. The median IBR value for the intestine was 7.33, markedly higher than that of the body wall (median IBR(B) = 5.97 × 10−2; Table 1). Specifically, the former was ca. 123-fold greater than the latter, indicating a significant difference in the integrated bioaccessible metabolite profiles between the intestine and body wall. As a concise metric, IBR effectively summarized the variation in multiple metabolites of interest across samples, enabling more sensitive comparisons of metabolic upregulation and downregulation between the intestine and body wall of A. japonicus, than could be achieved using any single peak area response alone. Star plot for IBR comparison of eight paramount metabolites in the arachidonic acid metabolism pathway, generated from the corresponding peak area responses. Image 1B and Image 2C represented the body wall and intestine samples of A. japonicus, respectively. Similarly, IBR values were respectively calculated and compared for metabolites included in the remaining enriched pathways of pyrimidine metabolism, purine metabolism, glycerophospholipid metabolism, tryptophan metabolism, arginine and proline metabolism, and cysteine and methionine metabolism. Overall, the IBR values obtained from the intestines were quite higher than those from the body wall samples (Table 1 and Fig. S3 in the Supporting Information). Notably, the metabolite C05822 (Fig. S3a) was downregulated in the intestine, indicating a more amount of 3’-CMP in the body wall. By integrating multiple metabolite responses within a compact multivariate area value, the IBR method rendered a quantitative gauge of metabolic alterations including upregulation and downregulation. Conclusions This untargeted metabolomic analysis characterized the metabolic profiles of A. japonicus intestine and body wall, underscoring the nutritive value of intestinal tissues via signature metabolites and key metabolic pathways. Lipids and lipid-like molecules, organic acids, nucleosides, nucleotides, and their analogues were annotated as the dominant metabolites in both tissues. A total of seven enriched metabolic pathways were identified from differential metabolites, primarily including arachidonic acid metabolism, pyrimidine metabolism, purine metabolism, and glycerophospholipid metabolism, among others. The highly abundant differential metabolites were mainly enriched in arachidonic acid and pyrimidine metabolism pathways, and most bioactive metabolites exhibited significantly higher abundance in the intestine relative to the body wall. The work provided a proof-of-concept evidence for the potential nutritional utility of A. japonicus intestine. Several limitations of this study should be noted. First, all specimens were collected from one single sampling location, which limit the generalizability of the present metabolic findings to other geographical populations of A. japonicus. Second, the baseline metabolic information derived in the study did not fully elucidate the direct causal relationships between differential metabolites, enriched pathways and intestinal physiological phenotypes. The intestinal enrichment of key metabolites merely suggested higher biosynthesis and tissue accumulation levels in intestinal tissues, while the gastrointestinal stability and bioavailability of these compounds remain unvalidated. Third, metabolite set enrichment analysis allowed statistical screening of perturbed metabolic responses by evaluating the collective alteration trend within metabolites sets. This analytical approach is suitable for quantifying enrichment significance, but cannot independently decipher the underlying biological mechanisms of metabolic alteration. Further experiments and functional assessments are required to verify the bioavailability and functional activity of intestinal metabolites. That will strengthen the objectivity and scientific rigor for evaluating A. japonicus intestines as a nutritional resource. CRediT authorship contribution statement Piaopiao Jiang: Writing – original draft, Visualization, Formal analysis, Data curation. Xu Zhou: Writing – original draft, Visualization, Formal analysis. Yun Hu: Writing – review & editing, Validation, Methodology. Jin Zhang: Writing – review & editing, Methodology. Boyan Li: Writing – original draft, Supervision, Project administration, Methodology, Formal analysis. Zhongda Zeng: Writing – review & editing, Supervision, Software, Resources, Methodology, Conceptualization. Ethics declaration Animal subject This study was conducted in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. This study was approved by the Ethics Committee of Guizhou Medical University (Approval No. 2200216). Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgements This work was funded by the National Natural Science Foundation of China (Grant no. 82360700). Footnotes Supplementary data to this article can be found online at https://doi.org/10.1016/j.fochx.2026.104389. Contributor Information Boyan Li, Email: Boyan_Li@hotmail.com. Zhongda Zeng, Email: zengzhongda@dlu.edu.cn. Supplementary data Supplementary material 1 Supplementary material 2 Data availability The data analysed in the study are available from the corresponding author on reasonable request. References Associated Data Supplementary Materials Supplementary material 1 Supplementary material 2 Data Availability Statement The data analysed in the study are available from the corresponding author on reasonable request.